| Kempen JH, Gangaputra S, Daniel E, et al.
Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the Evidence. [JOURNAL ARTICLE]
Am J Ophthalmol 2008 Jun 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Yao G, Albon E, Adi Y, et al.
A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children. [Journal Article]
Health Technol Assess 2006 Dec; 10(49):1-178.
Abstract | Full Citation | Find Related Articles |
| Woodroffe R, Yao GL, Meads C, et al.
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. [Journal Article]
Health Technol Assess 2005 May; 9(21):1-194.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Kempen JH, Daniel E, Gangaputra S, et al.
Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. [Journal Article]
Ophthalmic Epidemiol 2008 Jan-Feb; 15(1):47-55.
Abstract | Full Citation | Find Related Articles |
| Forbes C, Shirran L, Bagnall AM, et al.
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer. [Journal Article, Review]
Health Technol Assess 2001; 5(28):1-110.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Galor A, Jabs DA, Leder HA, et al.
Comparison of Antimetabolite Drugs as Corticosteroid-Sparing Therapy for Noninfectious Ocular Inflammation. [JOURNAL ARTICLE]
Ophthalmology 2008 Jun 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Masunaga Y, Ohno K, Ogawa R, et al.
Meta-Analysis of Risk of Malignancy with Immunosuppressive Drugs in Inflammatory Bowel Disease (January). [JOURNAL ARTICLE]
Ann Pharmacother 2007 Jan 2.
Abstract | Full Citation | Find Related Articles |
| Macdonald JK, McDonald JW
Natalizumab for induction of remission in Crohn's disease. [Journal Article, Review]
Cochrane Database Syst Rev 2006.:CD006097.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Macdonald J, McDonald J
Natalizumab for induction of remission in Crohn's disease. [Journal Article]
Cochrane Database Syst Rev 2007; (1):CD006097.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
New! 